Cargando…

Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort

BACKGROUND: Limited information exists on long-term prognosis of patients with sustained virologic response to antiretroviral therapy. We aimed to assess predictors of unfavorable clinical outcome in patients who maintain viral suppression with HAART. METHODS: Using data collected from ten clinic-ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gutierrez, Félix, Padilla, Sergio, Masiá, Mar, Iribarren, José A., Moreno, Santiago, Viciana, Pompeyo, Muñoz, Leopoldo, Sirvent, José L. Gómez, Vidal, Francesc, López-Aldeguer, José, Blanco, José R., Leal, Manuel, Rodríguez-Arenas, María Angeles, Hoyos, Santiago Perez
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762396/ https://www.ncbi.nlm.nih.gov/pubmed/17183720 http://dx.doi.org/10.1371/journal.pone.0000089

Ejemplares similares

Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
por: Masiá, Mar, et al.
Publicado: (2017)

Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors
por: Geskus, Ronald B., et al.
Publicado: (2016)

VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naïve HIV-Infected Patients
por: Jiménez-Sousa, María A., et al.
Publicado: (2019)

No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients
por: Gutierrez-Valencia, Alicia, et al.
Publicado: (2018)

Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort
por: Estrada, Vicente, et al.
Publicado: (2011)

Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?
por: Gutierrez-Valencia, Alicia, et al.
Publicado: (2015)

Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
por: Portocarrero Nuñez, Julian Alexander, et al.
Publicado: (2018)

Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir
por: Padilla, Authors: Sergio, et al.
Publicado: (2011)

Short-term Increase in Risk of Overweight and Concomitant Systolic Blood Pressure Elevation in Treatment-Naïve Persons Starting INSTI-Based Antiretroviral Therapy
por: Galdamez, Ronald, et al.
Publicado: (2019)

Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study
por: Masiá, Mar, et al.
Publicado: (2011)

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study
por: Masiá, Mar, et al.
Publicado: (2016)

Nuke-sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART Study
por: Carrero-Gras, Ana, et al.
Publicado: (2014)

Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic
por: Buzón, Luis, et al.
Publicado: (2023)

Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors
por: Alejos, Belén, et al.
Publicado: (2019)

Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients
por: Ramírez de Arellano, Eva, et al.
Publicado: (2019)

Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients
por: Masiá, Mar, et al.
Publicado: (2016)

1262. Dolutegravir Plus 3TC In Antiretroviral Experienced Adults: Immunovirological Outcomes In a Multicenter Retrospective Cohort In Spain
por: Buzón-Martín, Luis, et al.
Publicado: (2022)

Predictors of Pneumococcal Co-infection for Patients with Pandemic (H1N1) 2009
por: Masiá, Mar, et al.
Publicado: (2011)

Human Infection with Rickettsia sibirica mongolitimonae, Spain, 2007–2011
por: Ramos, José M., et al.
Publicado: (2013)

Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population
por: López-Cortés, Luis F., et al.
Publicado: (2014)

LINC-06. OBSERVATION ONLY IN A PATIENT WITH SUSPECTED LOW GRADE GLIOMA. SHOULD NEUROSURGERY ALWAYS BE THE FIRST STEP IN LOW AND MIDDLE INCOME COUNTRIES?
por: Leal - Cavazos, Carlos, et al.
Publicado: (2020)

LINC-11. Intrathecal methotrexate in a young child with medulloblastoma with extensive nodularity. An alternative to intra-ventricular route in Low and Middle Income Countries?
por: Leal-Cavazos, Carlos, et al.
Publicado: (2022)

Monotherapy with darunavir/ritonavir is effective and safe in clinical practice
por: Pasquau, Juan, et al.
Publicado: (2014)

Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain
por: Castro-Granell, Vanessa, et al.
Publicado: (2021)

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens
por: López-Cortés, Luis F., et al.
Publicado: (2016)

1571. BIC/FTC/TAF in Virologically Suppressed PLWHIV: 48-96 weeks RETROBIC Multicenter Cohort study results.
por: Estévez, Samuel, et al.
Publicado: (2023)

Predictors of Virologic Failure in HIV/AIDS Patients Treated with Highly Active Antiretroviral Therapy in Brasília, Brazil During 2002–2008
por: Bello, Edson José Monteiro, et al.
Publicado: (2011)

Coinfection with Human Herpesvirus 8 Is Associated with Persistent Inflammation and Immune Activation in Virologically Suppressed HIV-Infected Patients
por: Masiá, Mar, et al.
Publicado: (2014)

Contribution of Interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: A comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test
por: Ramos, José M, et al.
Publicado: (2012)

Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
por: Oliveira, Marta Iglis, et al.
Publicado: (2018)

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
por: Palumbo, Philip J., et al.
Publicado: (2017)

Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs
por: Fuster-RuizdeApodaca, María José, et al.
Publicado: (2020)

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
por: Abdissa, Alemseged, et al.
Publicado: (2014)

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain
por: Diaz, Asuncion, et al.
Publicado: (2010)

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2017)

Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa
por: Westreich, Daniel, et al.
Publicado: (2011)

Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study
por: Minguez, Carlos, et al.
Publicado: (2014)

Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy
por: Medrano, Luz M., et al.
Publicado: (2018)

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
por: Larru, Beatriz, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_9ipoa2gp7rfiqo9f5s36n1r44o